ARMRA
Facts-only compliance record. Every entry is source-backed and dated.
Last reviewed: 2026-04-15
Event Timeline
BBB F rating with 48 complaints; stopped responding since March 2024
ARMRA holds an F grade on BBB with a 1.14-star customer rating. Not BBB-accredited. 48 complaints in last 3 years, primarily about subscription cancellation and billing. ARMRA stopped responding to BBB complaints since March 2024.
IgG disclosed as percentage range but not per serving
ARMRA discloses IgG concentration as a percentage range (35-40%+) but does NOT disclose per-serving IgG amounts, making potency assessment impossible. No published independent IgG verification. No NSF, USP, Informed Sport, or Clean Label Project certifications.
Lead Safe Mama detects arsenic in Colostrum Immune Revival
Independent lab testing by Lead Safe Mama found ARMRA Colostrum "Immune Revival" tested positive for arsenic in the double-digit ppb range. Separately, Mamavation testing found ARMRA negative for PFAS and phthalates (a positive result).
TINA.org: $1.8M TV ad spend on problematic claims, pattern of claim-then-retreat
Truth in Advertising found ARMRA spent nearly $1.8M on TV ads making problematic claims including "improve focus" and "reactivate hair growth" (drug claims requiring FDA approval). After TINA's April 2024 findings, ARMRA removed the "3X more effective than flu vaccine" claim but then launched 3 new TV commercials continuing similar claims.
Hair growth class action filed then voluntarily dismissed
Class action targeting ARMRA's unsubstantiated hair growth marketing claims. Hair growth claims have no peer-reviewed support for bovine colostrum. Case was voluntarily dismissed with prejudice by plaintiff on May 31, 2024 (no reason given in filing).